Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20101
20111
20141
20152
20191
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore2
ALX Oncology Inc.1
AbbVie (prior sponsor, Abbott)1
AstraZeneca1
Celgene1
GlaxoSmithKline1
NantCell, Inc.1
National Cancer Centre, Singapore1
Novartis Pharmaceuticals1
Odonate Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis14
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms2
Nasopharyngeal Carcinoma2
Recurrence2
Stomach Neoplasms2
Adenocarcinoma1
Adenocarcinoma of Lung1
Carcinoma, Adenoid Cystic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.